Which Markets Should MedTech Localize First? A 40-Market Model (2026)

TL;DR

Do not ask “Which three countries rank highest?” and call the answer a localization strategy. A market rank, a language investment and a full working locale are three different decisions.

VayoMed Research built a 40-market worked example for a diagnostic-ultrasound manufacturer. We screened countries on aligned 2022 World Bank inputs, then made product demand—not generic population or healthcare spending—the majority of the score. The demand lane is importer-summed trade in HS 901812, ultrasonic scanning apparatus, for 2022–2024. The base model weights three-year median imports at 45%, import momentum at 15%, internet use at 15%, logistics at 10%, health spending per person at 10% and population aged 65+ at 5%. Five frozen weighting scenarios test whether the shortlist survives a different executive's priorities [1][2][3].

The market screen puts the United States, Netherlands and Germany in the top three under every scenario. But an English-source manufacturer should not answer that result by building three translated sites. The United States needs an en-US market journey, not a new language. The Netherlands needs a focused commercial page and a redistribution check because imports may not equal final domestic use. Germany merits a full German working locale whose controlled core can support an Austrian market journey.

The best first-wave language portfolio in this worked example is therefore:

1. German for Germany, with an Austria-specific market layer. Germany ranks #3 and never leaves the top three; Austria ranks #4 in all five scenarios.
2. Korean for South Korea. Korea ranks #6 in the base case, stays between #5 and #11, and its observed import value rose from $127.7 million in 2022 to $138.6 million in 2024.
3. Spanish for Spain. Spain ranks #9, stays between #7 and #12, and its observed import value rose from $83.8 million to $100.2 million over the same period.

Those are not unconditional market-entry recommendations. They are the three full-locale investments that survive the quantitative screen if the manufacturer passes approval, claims, distributor, service and evidence-owner gates. Germany's MPDG, Korea's Medical Devices Act and Spain's AEMPS materials also make clear that local-language product information is an operating reality, not only an SEO preference [4][5][6]. A marketing translation does not supply regulatory clearance, compliant labeling or an authorized service network.

Japan and China are the counterexamples that make the model useful. Japan ranks from #5 to #14 across scenarios while its HS 901812 imports fell 14.7% annually from 2022 to 2024. China ranges from #6 to #27 while its observed value fell from $573.6 million to $305.2 million. Both deserve a bounded, local-language market page and operating validation if the manufacturer is actually pursuing them; neither deserves a full locale merely because one headline number is large.

The report assigns all 40 markets to one of four default depths: three full locales, 12 market-page tests, 17 English-only markets and eight deferrals. It then gives one .com architecture, a 90-day rollout and stop/expand rules. The result is not “translate more.” It is “fund only the local evidence you can keep accurate, discoverable and commercially operable.”

1. The category mistake: a top market is not automatically a new language

Takeaway: A country can be commercially important without requiring a new language, and one language investment can support more than one country. Start with a market decision, convert it into a publishing depth, then choose the language asset.

Most localization plans begin with a menu. Someone proposes German, French, Spanish, Japanese and Chinese because those options look “global.” A distributor asks for a translated brochure. A competitor has seven flags in its header. A market forecast calls China or the United States the largest region. The team then buys translation as if adding strings to a content-management system were the expansion decision.

That sequence hides three different questions:

1. Market question: Is there enough product-specific opportunity, accessible demand and operating capacity to justify attention in this country?
2. Publishing-depth question: Does the country need a complete working locale, one local market journey, the global English site, or no active investment yet?
3. Language-portfolio question: Which reusable language core creates the most credible market journeys per unit of ongoing governance?

The United States shows why the separation matters. It is #1 in our worked example and imported $543.2 million of HS 901812 apparatus in 2024. For a company whose source site is already English, “translate for the US” is meaningless. The actual work is an en-US journey: US-cleared products, US terminology, compatible evidence, local service coverage, a real contact route and only the claims allowed for that device and audience. The market investment is real even though the language count does not change.

Germany and Austria show the opposite pattern. They are separate countries with different commercial, reimbursement, contact and legal details. But the company does not need two independent translation estates. It needs a governed German source layer and country-specific modules under it. The reusable asset may include navigation, product-category explanations, evidence summaries and service concepts; the Germany and Austria market pages still need their own approved claims, availability, contacts and disclosures.

Spanish creates a third pattern. A Spain-first locale can later reduce the cost of testing Mexico, Colombia or Chile, but it cannot turn “Spanish” into one market. Local product authorization, responsible parties, reimbursement, distributor identity, service expectations and vocabulary remain country specific. Language reuse is an efficiency. It is not regulatory passporting.

The right unit of planning is therefore not “number of translations.” It is a portfolio of working country journeys backed by a smaller number of governed language cores.

What “full locale” means in this report

A full locale is not a translated home page plus a language switcher. It is a maintained buyer journey with at least:

• local navigation and terminology;
• product/category and clinical-application pages appropriate to that market;
• evidence and quality/regulatory pages with an identified claims owner;
• current availability, service, warranty and distributor information;
• contact routing that reaches someone able to respond in the stated language;
• IFU, e-label or product-information links where appropriate and lawful;
• local FAQs, search-intent content and updates after launch;
• technical internationalization, measurement and a retirement process.

If the company cannot name the person who owns those items after launch, it does not have a full locale. It has a translation project with an expiry date.

What “market page” means

A market page is a deliberately bounded validation surface. It can be one strong page or a small cluster, written in the local language where needed, that answers five buyer questions: what is available here, for whom, with what evidence, who supports it and what should the buyer do next? It does not pretend that the whole global site has been localized.

A market page is particularly useful when demand looks material but one of four uncertainties remains: import flow may be redistribution; ranking is sensitive to weights; a distributor or service route is not yet proven; or the company needs evidence of local discovery before committing to a full content operation.

What “English-only” and “defer” mean

English-only means the global English site remains discoverable and the company does not fund a dedicated local page in the current wave. It does not mean English satisfies the country's labeling, IFU, promotional or contracting rules. The designation is a website-budget choice, not a compliance opinion.

Defer is more active than “ignore.” It means the company will not create a market promise it cannot operate. Reasons can include low relative priority, no approval path, sanctions or payment risk, no service owner, no responsive distributor or insufficient evidence. A deferred market keeps a named revisit condition. It does not acquire a decorative flag.

2. The model: what was scored—and what was deliberately left as a gate

Takeaway: The model gives product demand 60% of the base weight, aligns the macro screen to one common year, imputes nothing and tests five plausible executive priorities. It refuses to bury regulatory access and service readiness inside an invented “ease” score.

This is a worked example for a manufacturer of diagnostic-ultrasound systems, not for medical devices as a single undifferentiated category. A localization model that gives the same answer to an ultrasound manufacturer, an IVD company, a wound-care supplier and a surgical-robot business is not a serious model. The product-specific lane must change with the product.

2.1 The 40-market candidate screen

The World Bank source panel contained 217 entities with a 2022 row. We required six complete inputs and used no imputation, leaving 132. We calculated total current health expenditure from current-dollar GDP and current health expenditure as a share of GDP, then retained the 40 largest totals. The World Bank defines the expenditure share as current public and private health spending relative to GDP; it is not a device-market forecast [2].

Why 2022 when this report is dated 2026? Because comparable beats cosmetically recent. The current Logistics Performance Index observation in the panel is 2022; using a 2023 row while silently carrying 2022 logistics would create a mixed-year score that looked fresher without containing fresher operating evidence. The LPI is also a 1–5 perception-based assessment across six logistics dimensions, not an objective service-network measure [3].

The 40-country screen is only a bounded universe for deeper analysis. It prevents the report from cherry-picking familiar markets after seeing the trade result. It does not say that a country outside the 40 can never be attractive for a specialized product.

2.2 The demand cohort: HS 901812, 2022–2024

The independent demand lane is CEPII BACI HS 2017 code 901812, “ultrasonic scanning apparatus.” BACI provides reconciled bilateral trade flows by year, exporter, importer and six-digit product; its 202601 release covers through 2024. CEPII reconciles exporter and importer declarations sourced from UN Comtrade and estimates transport-cost adjustments, so BACI values can differ from raw Comtrade [1].

We scanned 34.66 million bilateral rows across 2022–2024 and summed positive HS 901812 flows by importer for the 40 candidates. The three-year median import value is the scale measure. The 2022–2024 compound annual growth rate is the momentum measure. Values are current US dollars.

Three guardrails matter:

• Import value is a proxy for product flow, not manufacturer revenue.
• An importer can be a distribution or re-export hub; the Netherlands must be validated on final-use and channel evidence.
• A falling import series can reflect inventory, sourcing, local production, classification or volatility. It is a reason to investigate—not proof that clinical demand collapsed.

This demand lane replaced an apparently convenient R2 ultrasound trade file. The rejected file had 136,421 rows but every reporter, reporter ISO, partner and partner ISO field was null. Without a country dimension it could not answer the research question. “More rows” is not “better evidence.” The full rejection and checksums are preserved in the Phase 1 record.

2.3 Six factors, transparent weights

The frozen base score is:

The 5th/95th percentile winsorization reduces outlier dominance without deleting countries. Log transforms stop the largest import and spending observations from overwhelming every other signal. Momentum is capped because a tiny starting value can produce an enormous CAGR that is commercially trivial.

Demand and momentum total 60%. That design answers the original quality gate: a macro panel can screen markets but cannot rank them alone. Internet access, logistics, spending capacity and age provide context. None substitutes for the product.

2.4 Five scenarios, not one magic score

Composite scores encode priorities. Pretending otherwise turns an analyst's preference into fake objectivity. We therefore froze five scenarios before interpreting the results:

A market enters Tier A when it ranks in the top ten in at least four of five scenarios. Tier B requires a top-15 rank in at least three scenarios without already qualifying for A. Everything else is Tier C. This rule rewards stable shortlist membership rather than one decimal point in the base score.

The model does not assign numeric values to registration, reimbursement, sanctions, language burden, distributor quality, service coverage or claims readiness. Those dimensions are specific to the product and company. Turning them into generic country numbers would obscure the conditions that actually stop a launch. They remain hard gates after the screen.

Reading note: A stable market rank is not yet a language decision.

3. The result: stable markets, sensitive markets and false shortcuts

Takeaway: Six markets are stable top-ten candidates, but only three become new full locales. Japan and China demonstrate why a large market number should trigger validation rather than automatic translation.

The 40 candidates imported $4.22 billion of HS 901812 apparatus in 2024. The United States, Germany and Netherlands together represented 30.0% of that candidate-set total. The number is evidence of concentrated product flow, not a claim about the global ultrasound market or the three countries' final-use share [1].

The top 15 base results are:

The base ranking is not a league table of “best medtech markets.” It is the input to a resource decision for one cohort. Three patterns matter more than the exact order.

3.1 The stable four reveal an asset-reuse opportunity

The United States, Netherlands and Germany never leave ranks 1–3. Austria is #4 in all five scenarios. If the team followed country rank literally, it would spend the first wave on four country sites. That would miss the portfolio logic.

An English-source company already owns the basic US language layer. The work is local market evidence. Germany and Austria can share a German content core. The Netherlands may operate effectively with Dutch and English, but the commercial case depends on whether the measured import flow represents buyers the manufacturer can serve or logistics it cannot monetize. The first four countries therefore imply one new full language core, three focused market journeys and one distribution validation, not four standalone sites.

3.2 Korea and Spain are less flashy and more actionable

Korea and Spain are the only other markets that satisfy the Tier A stability rule. Neither leads the headline import table. Both combine meaningful product flow, positive 2022–2024 direction and strong internet use. Korea's 2024 observed value is $138.6 million, up from $127.7 million. Spain's is $100.2 million, up from $83.8 million [1].

Their language assets are also operationally distinct. A Korean locale cannot be borrowed from another first-wave market. Spanish can later support other country tests, but Spain's regulated and commercial content still needs Spain- specific control. This combination—stable shortlist membership plus a clear local-language operating need—is what earns full-locale status.

3.3 Japan is attractive, but its rank is not stable enough for an automatic full build

Japan is #5 in the base model and has the oldest population share in the 40- market set. An equal-weight executive, however, moves it to #14, and the digital-first scenario places it #12. Observed HS 901812 value fell from $230.1 million in 2022 to $167.5 million in 2024, a -14.7% CAGR [1].

That does not make Japan a poor market. It changes the next action. A company with approval, a capable local partner, Japanese support and a current product information process may promote Japan into the full-locale wave. A company without those facts should first build a bounded Japanese market journey, test the actual queries and contact path, and verify who will maintain it.

3.4 China is the clearest warning against market-size reflexes

China has the second-highest 2022 import value in the candidate set at $573.6 million and remains $305.2 million in 2024. A demand-heavy executive ranks it #6; an equal-weight executive ranks it #27. The range is not a rounding issue. It says the decision depends heavily on how much the company trusts import scale relative to momentum, digital reach, spending capacity and logistics context.

China also has an explicit language and access gate. Current rules require Chinese instructions and labels for imported medical devices; non-compliant Chinese product information blocks import [7]. A Chinese marketing page cannot solve market access. It can become a truthful validation surface only after the manufacturer knows which product, registration, local entity, distributor, service and claims path it can support.

Reading note: Japan and China are high-volume but materially weight-sensitive.

Reading note: Spain and Korea strengthened while Japan and China declined.

3.5 Rank movement is information, not model embarrassment

A single composite score tempts teams to defend the model whenever the result changes. The better response is to use movement as a diagnostic.

• Narrow range: the market remains relevant under different priorities. It deserves operating diligence.
• Wide range with high demand: validate channel quality, final use and access before investing in a full locale.
• Wide range driven by digital or logistics context: determine whether the company's distributor and support model neutralizes the macro weakness.
• Lower base rank but positive momentum: retain a monitor trigger; do not build ahead of the commercial system.

The output is a shortlist with reasons. It is not a forecast of localization ROI.

4. Convert the rank into four publishing depths

Takeaway: The default matrix allocates only three full locales. Twelve markets receive a bounded page test, 17 remain on global English and eight are deferred. Any failed access or operating gate overrides the default.

The quantitative screen tells a team where to investigate. It cannot know whether this specific manufacturer is cleared, reimbursed, represented, serviceable or contractually able to sell. The four-depth matrix therefore uses a second stage.

4.1 Five gates come before any full locale

For each candidate, require a named owner to answer five questions.

A failure on market access or truthful service should move the market directly to defer, even when it ranks #1. A weak language-operation gate usually moves a full locale to a smaller market page. A proven local distributor, strong query-level demand and service readiness can promote an English-only market to a page test even when its model rank is lower.

This override is not a flaw. It is the line between public-data screening and actual management.

4.2 The default 40-market matrix

The table below assumes an English source site and no undisclosed company- specific advantage. “Market page” can be in a local language and can be a small cluster; it is not necessarily English. “English-only” means no funded country journey in the current wave, not a regulatory-language opinion.

The default is reproducible: select three distinct non-English Tier A language investments after accounting for the existing English source, shared-language reuse and an unresolved Netherlands final-use question; assign every other Tier A/B market a page test; keep Tier C ranks 16–32 on global English; and defer ranks 33–40. Russia is the one access-governance exception moved from English- only to defer; South Africa is the one lower-ranked exception retained on global English because it requires no new language asset. Company facts can override the default only through the five recorded gates.

Reading note: Only three of 40 screened markets justify a full first-wave locale.

The matrix is intentionally conservative. Its job is to stop a team from publishing 40 weak promises. It does not say markets ranked 16–40 lack patients, clinicians or clinical need. It says the current evidence does not justify funding a separate country content operation before the higher-priority paths are working.

4.3 Regulatory language is a gate, not a factor score

In the European Union, the Medical Device Regulation requires the manufacturer to supply specified information with the device and, where the manufacturer has a website, to make current information available there; member states determine the languages accepted for users and patients [8]. That framework is one reason a generic “European language difficulty” score would be misleading. Country rules and audience details matter.

Germany's MPDG §8 requires user/patient information in German. It allows a bounded alternative for devices supplied exclusively to professional users when justified, but safety-related information remains in German or the user's language [4]. France's current Public Health Code Article R5211-3, in force from 22 April 2026, requires specified label, IFU, implant, declaration and safety-notice information in French [9]. Spain's authority states that label and IFU information supplied in Spain must be at least in Spanish or Castilian [6].

Korea's Medical Devices Act Article 23 requires the specified descriptions under the preceding labeling provisions to be accurate in Korean using terms that are easy to understand [5]. Japan's PMDA directs electronic package-insert access through Japanese-language product-information systems [10]. China's current regulatory framework requires Chinese instructions and labels for imported devices [7].

English-speaking markets also require precision. In the United States, 21 CFR 801.15 generally requires mandatory labeling information in English; if a label contains a representation in another language, the required information must also appear in that language [11]. Canada distinguishes professional-use and general-public devices: professional information must be in at least English or French with the other official language available on request, while general- public directions are required in both [12]. Current UK and Australian authority guidance similarly places the website inside a broader manufacturer, sponsor, labeling and conformity context—not above it [13][14].

The practical rule is simple: never copy the marketing site's language menu into the product-information workflow without regulatory review, and never cite a compliant IFU as proof that the full buyer journey is localized. The two systems must connect, but they are not the same artifact.

5. Why German, Korean and Spanish win the first-wave portfolio

Takeaway: The first wave is not the next three country ranks. It is the combination of one reusable two-country German core, one high-digital Korean journey and one growing Spain-first Spanish core.

5.1 German: build one governed core, then separate Germany and Austria

Germany scores 87.2 in the base model, ranks #3 and remains between #1 and #3 in all scenarios. Its 2024 HS 901812 import value is $374.4 million, following $394.7 million in 2022 and $357.0 million in 2023. The small decline is not enough to dislodge it because product scale, logistics, spending capacity, digital reach and age structure remain strong [1][3].

Austria is even more stable in rank: #4 under every scenario, with $217.6 million observed in 2024. The unusual combination means German has portfolio leverage. One controlled content source can support two distinct market journeys at launch.

That source should include:

• a German terminology and claims glossary tied to the approved English source;
• category and clinical-application explanations for the exact offered systems;
• evidence modules that preserve population, comparator and endpoint context;
• quality, regulatory and product-information routing;
• service, installation, training and warranty concepts that can accept country-specific values;
• a German FAQ and search-intent backlog;
• separate Germany and Austria contact, availability and partner modules.

The Germany page must not imply that an Austrian distributor covers Germany, or vice versa. The same sentence can also require different disclosures, pricing context or product availability. Reuse the language core; localize the market promise.

A bounded German query check on 29 August 2026—Ultraschallgerät kaufen medizinisch Hersteller Deutschland—returned German equipment vendors, distributors and service/comparison pages, including category-led commercial pages rather than translated corporate manifestos [15]. The observation does not provide query volume or predict ranking. It does tell the content team what page forms it is entering: product selection, applications, service and supplier credibility.

Full-locale launch condition: the German reviewer, Germany commercial owner and service escalation owner sign the same release checklist. If only the translation vendor is named, ship a Germany market page instead.

5.2 Korean: treat local product information and buyer response as one operating lane

South Korea ranks #6 in the base model and remains #5–#11 across all scenarios. Its internet-use input is 97.2%, among the strongest in the candidate set. HS 901812 import value moves from $127.7 million in 2022 to $125.8 million in 2023 and $138.6 million in 2024, a two-year CAGR of 4.2% [1].

Korean earns a full locale because the quantitative case and the operating- language case point in the same direction. Article 23's Korean description rule does not mean every marketing page is prescribed by that article. It means the company should not run a polished Korean acquisition layer disconnected from the controlled Korean information that supports the product [5].

The Korean core should prioritize:

• product/category pages using the terminology customers and authorities recognize, not machine-translated US shorthand;
• application pages that state intended users and settings precisely;
• evidence pages with study population and device/version context intact;
• product-information and support routes that do not dead-end in English;
• local distributor/service identity and a Korean response SLA;
• market-specific FAQs drawn from qualified sales and support questions;
• a native review of navigation, forms, consent, typography and mobile layout.

A bounded Korean query check—의료용 초음파 진단기 구매 제조사—surfaced Korean health/reimbursement information alongside commercial content [16]. Again, this is not a volume study. It is a reminder that a Korean buyer journey intersects institutional terminology and local information systems, not only product adjectives.

Full-locale launch condition: a Korean-speaking owner can answer a qualified request, trace every marketed product to current controlled information and route installation/service questions. If the answer depends on forwarding an untranslated email to headquarters, the operational layer is not ready.

5.3 Spanish: launch for Spain, design the content model for later country reuse

Spain ranks #9 in the base model and stays between #7 and #12. Its HS 901812 import value rises from $83.8 million in 2022 to $115.5 million in 2023 and $100.2 million in 2024. The 2024 value is below the one-year peak but still produces a 9.4% CAGR from the 2022 base [1].

Spanish wins the third full-locale slot over Japanese or Chinese in this worked example because its rank is more stable, its observed direction is positive and its language core offers future reuse. That is not a forecast that Spain will produce more revenue. It is a decision that Spain is the lower-regret first full-locale investment under the published model.

The Spain launch should contain:

• Castilian Spanish product and category terminology reviewed for the intended audience;
• Spain-specific product availability, entity/distributor and service details;
• evidence and claims modules tied to the applicable approved source;
• AEMPS/product-information routing where relevant;
• Spain-specific forms, phone conventions and privacy copy;
• a local FAQ and content plan informed by actual Spanish queries and sales objections;
• an explicit content schema separating language = es from market = ES.

That last item protects later expansion. A Mexico page can inherit language components but must replace the access, product, distributor, service, pricing, contact and claims context. Colombia, Chile and Argentina require the same discipline. “We already translated Spanish” is a production fact, not a market- entry fact.

Full-locale launch condition: the Spain regulatory/claims owner and commercial/service owner approve the market modules; the translation memory labels country-specific terms; and analytics can distinguish Spain from later Spanish-speaking markets.

Reading note: Three full locales support four first-wave country journeys.

5.4 The minimum viable full locale is eight connected modules

Do not sequence the first wave as home page, about page, careers, then whatever is easy. Sequence around the buyer's decision:

1. Market landing page: who the company serves here and what is actually available.
2. Product/category page: systems, configurations and intended-use language appropriate to the market.
3. Clinical application: the problem, workflow and evidence boundary.
4. Evidence center: source-grounded claims, studies, technical documents and version dates.
5. Quality/regulatory path: clear, non-promotional navigation to controlled information and local responsible parties where appropriate.
6. Service and support: installation, training, warranty, maintenance, parts and escalation.
7. Distributor/contact: named routing with language capability and response ownership.
8. FAQ and ongoing content: local buyer questions, not an auto-translated global blog archive.

The module list is deliberately smaller than “translate the whole site.” A full locale earns the label through completeness of the decision path and ongoing operations, not page count.

6. What to do with the other high-volume markets

Takeaway: A lighter page is not a consolation prize. It is the correct instrument for a high-priority market whose language, channel or access case is not yet ready for a permanent content operation.

United States: localize the journey, not the language

The US page should answer US-specific questions: which systems are cleared and available, how the product is described in the relevant US evidence, who sells and supports it, what training or service exists, and how a qualified buyer gets an answer. Use en-US metadata and vocabulary where the site architecture needs to distinguish the page from global English.

Do not use the US page as a dumping ground for every corporate claim. Under 21 CFR 801.15, language choices in labeling carry consequences [11]. The page should point to current controlled information rather than rewrite it loosely for SEO.

Validation question: Does the US page produce discoverable, product-specific impressions and qualified routes that the global home page did not, while maintaining claim accuracy?

Netherlands: test final-use demand before building a Dutch content estate

The Netherlands ranks #2 and shows $348.9 million in 2024 imports. That is too large to dismiss and too exposed to distribution-hub effects to treat as final domestic demand. The first page should be built around the company's actual Dutch availability and European channel—not around the aggregate number.

Interview the channel owner and inspect order destinations, tenders, service requests and qualified searches. If the opportunity is Dutch hospitals and clinics, add native Dutch modules. If most value reflects onward distribution, the page's job may be partner support or logistics rather than domestic demand generation.

Validation question: Which share of the company's reachable opportunity has a Dutch buyer, Dutch service requirement or Dutch-language discovery path?

Austria: make German reuse visible, but keep the market promise separate

Austria is #4 in every scenario. It does not need a second German site. It needs an Austrian route under the German locale: availability, partner, product, contact and support details for Austria, with shared evidence and category modules where they are genuinely equivalent.

The architectural win is measurable. The company maintains one German glossary, one common claim source and one technical locale while owning two country journeys. The governance test is whether country modules can change without forking the entire German content tree.

Validation question: Can a buyer tell who serves Austria and what is available there without reading Germany-specific assumptions?

Japan: publish the decision path before translating the library

Japan deserves a high-quality Japanese market page because its base rank and absolute imports are material. It does not automatically deserve a full locale because its scenario range is wide and its recent observed trade direction is negative. The pilot should contain the exact product, applications, evidence, local entity/partner, service and product-information route. It should not translate a backlog of generic thought leadership.

PMDA's electronic package-insert surface is Japanese-first [10]. A bounded Japanese query check for medical-ultrasound purchasing also surfaced a Japanese public procurement notice, not merely manufacturer home pages [17]. That observation suggests a local journey may need procurement- ready specifications and support evidence. It does not estimate the query's volume.

Validation question: Can a Japanese buyer move from local discovery to current product information and a Japanese-capable commercial/service owner without switching into a different promise?

France and Italy: preserve the Tier B signal, require local ownership

France and Italy rank #7 and #8 in the base case, but each moves outside the top ten under some scenarios and shows a negative 2022–2024 CAGR. Both justify country-page diligence because of their scale, European market role and local language reality. Neither should become a full locale until the company can demonstrate active product/channel/service readiness.

France's current language requirement is explicit [9]. A bounded French query for buying a medical ultrasound system surfaced French product catalogues, including a local-language manufacturer commerce surface [18]. A useful pilot therefore needs product selection and support content—not a translated mission statement.

Italy should use the same principle. The company should publish only the systems available through the Italian route, with an Italian reviewer and response owner. When local impressions, qualified contacts, distributor use and service outcomes justify ongoing work, the page cluster can become a full locale.

United Kingdom, Canada and Australia: shared language does not mean shared page

These three markets can reuse English source content, which lowers production cost but does not erase market differences.

• The UK page needs en-GB terminology, GB availability, the appropriate local entity and current MHRA/GB compliance context [13].
• Canada needs a country journey that handles English/French product-information obligations for the audience and a real Canadian route [12].
• Australia needs its local sponsor, ARTG/product context and support path; current TGA guidance places labeling and manufacturer information inside that system [14].

The work in these markets is localization even when translation volume is low. Country evidence, product status, service and contact ownership are the content.

Norway and Switzerland: do not confuse high purchasing capacity with one language choice

Norway ranks #13 and Switzerland #14. Both score strongly on spending and digital/logistics context, but their product scale is smaller and their scenario ranges reach #17 and #19. A page test is proportionate.

For Norway, begin with the actual buyer language and channel. For Switzerland, do not create a generic “Swiss” localization. Choose the linguistic region and audience supported by the commercial route. A German-language Swiss page, for example, can reuse components from the German core but still needs Swiss availability, contact and claims governance.

China: no access, no page

China is the only Tier B market whose default market page carries an explicit access gate in the matrix. The rule should be literal. If the exact device lacks the route, local entity, Chinese controlled information, channel or service support needed for a truthful offer, do not publish a demand-generation page.

If the gates pass, start with a bounded Chinese journey for the approved product. Measure whether local discovery reaches the correct entity and whether qualified contacts can be handled. Only then decide whether the high-demand scenario is a better reflection of the company's reality than the digital/equal-weight cases.

The Tier C rule: a trigger, not a translation backlog

Seventeen Tier C markets remain English-only in the default matrix. That queue should not turn into “translate when there is time.” Give each market promotion triggers:

• verified approval or an active submission with a credible commercial date;
• a contracted and enabled distributor or direct market owner;
• repeated qualified local-language inquiries, tender activity or support use;
• service coverage and response capacity;
• enough local query/category evidence to define a page's job;
• a named language and claims reviewer.

When two or more triggers become real, evaluate a market page. When the page proves sustained demand and operations, evaluate a full locale. This sequence prevents sales anecdotes from becoming permanent technical debt while allowing real opportunity to override a lower macro rank.

7. Build one international site, not a fleet of disconnected sites

Takeaway: Default to one .com with language subdirectories, explicit country paths, reciprocal hreflang only for true equivalents and one governed claim source. Register ccTLDs defensively when justified; do not create separate content estates by default.

Google recommends different URLs for different language versions, visible links between them and no automatic redirection based on a guessed language. It notes that subdirectories on a generic top-level domain are easy to set up and low maintenance, while country-code domains offer clearer geotargeting but require more infrastructure [19]. For a resource-constrained medtech team, that trade-off favors one governed site.

7.1 Recommended URL model

https://example.com/                         x-default / global selector
https://example.com/en/                      global English
https://example.com/en/markets/us/           United States journey
https://example.com/en-gb/markets/uk/        United Kingdom journey when warranted
https://example.com/de/                      German locale core
https://example.com/de/maerkte/deutschland/  Germany journey
https://example.com/de/maerkte/oesterreich/  Austria journey
https://example.com/ko/                      Korean locale core
https://example.com/ko/markets/korea/        Korea journey
https://example.com/es/                      Spanish locale core
https://example.com/es/mercados/espana/      Spain journey
https://example.com/ja/markets/japan/        Japanese market-page pilot

The exact path words are a product decision; consistency matters more than whether every directory uses English or the local language. The model must store language and market as separate fields. A German-language Switzerland page and a German-language Germany page share language = de but not market, entity, availability or owner.

7.2 hreflang is an equivalence map, not a ranking button

Google's localized-version guidance requires supported language/region codes and recommends reciprocal, self-referential annotations; x-default can identify a neutral selector or fallback [20]. Only pages that are meaningful alternatives should be connected.

If the Japanese pilot is one market page while German has an entire locale, do not point every German URL to the single Japanese page as if they were equivalent. If a product is unavailable in Korea, do not place the Korean market home in the hreflang cluster for that product. A technically complete but semantically false map misroutes users and search systems.

Each published equivalent should have:

• its own canonical URL;
• a self-referential hreflang entry;
• reciprocal entries on its genuine equivalents;
• an appropriate language or language-region code;
• an x-default only when a real neutral/fallback page exists;
• inclusion in the relevant XML sitemap or HTML annotations, with one method governed consistently;
• visible navigation a user can operate without an IP redirect.

The 2025 HTTP Archive Web Almanac found hreflang on about one-fifth of pages: 20.3% in raw desktop HTML and 19.7% in raw mobile HTML [21]. That is a benchmark for implementation prevalence, not evidence that hreflang creates demand or that the other four-fifths should localize.

7.3 Use ccTLDs as portfolio assets, not automatic publishing platforms

IANA's root-zone database can confirm whether .de, .at, .kr, .es, .jp or another top-level domain is delegated and active [22]. It cannot tell the company whether it is eligible to register, what the domain costs, whether the name infringes a mark, or whether a country site will rank.

The practical policy is:

1. Keep the governed content on the .com subdirectory architecture.
2. Register high-risk or commercially important ccTLDs after eligibility, trademark, naming and security review.
3. Redirect defensive domains to the exact country journey when that journey exists; do not redirect every domain to the global home page forever.
4. Create a separate ccTLD content estate only when local legal, commercial, operational or platform constraints justify the duplication—and fund its independent maintenance.

The domain register should record owner, registrar, renewal, DNS, security, redirect target, market purpose and retirement rule. A flag menu is not a domain strategy.

7.4 One controlled claim source, many approved renderings

The hardest localization problem is not sentence translation. It is preventing the product claim from drifting across language and country versions.

Create a claim/evidence record with at least:

The content-management system should render approved modules from that source, not copy-paste paragraphs into disconnected pages. If evidence changes, the owner can find every affected locale. If a market has no approved rendering, the page cannot silently borrow one.

7.5 Technical release checks are necessary but not sufficient

Before launch, test:

• status, canonical, indexability and sitemap membership for every target URL;
• reciprocal hreflang and correct language-region codes;
• language switcher behavior on desktop, mobile and keyboard navigation;
• no automatic forced redirect that prevents users or crawlers choosing a page;
• forms, consent, phone/email routing and thank-you pages in the correct language;
• structured data whose claims and market fields match the visible page;
• asset alt text, captions, units, date formats and text expansion;
• page speed and layout in Korean, German and Spanish—not only English;
• analytics dimensions for page, language, market, query, source and qualified outcome;
• a 404/redirect plan when a market page or locale is retired.

Passing these tests proves the system was implemented. It does not prove buyers will discover, trust or contact it. That is why the rollout reserves the final month for native evidence and measurement.

8. A 90-day rollout with stop and expand rules

Takeaway: Days 1–15 decide whether the company is allowed and able to make the promise. Translation begins only after those gates. Days 61–90 decide whether the locale earns continued investment.

Reading note: The first month is an operating gate, not a translation sprint.

Days 1–15: access, ownership and baseline

Create one row for Germany, Austria, Korea, Spain and every priority market-page test. Do not begin production until the row has named owners.

The baseline is important because a team cannot later claim “localization worked” from a global traffic increase. Record page-level impressions and clicks by country and query where available; qualified forms and their disposition; distributor use; support requests; and current branded/non-branded discovery. Do not fabricate search volume when the denominator is unavailable.

At the end of day 15, hold a go/no-go meeting by market. Germany, Korea or Spain that fails a hard gate becomes a market page or defer. The next qualified market can enter the full-locale slot, but the reason must be documented. The model is a sequence, not a command to publish unsupported content.

Days 16–35: build the three source cores and four country journeys

Build German, Korean and Spanish from approved modules, not parallel ad hoc documents. Germany and Austria use one German core with separate country fields. The sprint order is buyer-path first:

1. market landing and product/category;
2. application and evidence;
3. quality/regulatory/product-information route;
4. service, training and warranty;
5. distributor/contact and response workflow;
6. FAQ, glossary and first native query pages.

Run linguistic, medical/regulatory and commercial review as separate checks. A linguistically excellent translation can still broaden a claim. A compliant product phrase can still lead to an unstaffed form. A commercially persuasive page can still advertise a configuration unavailable in the market. All three reviews matter.

Do not translate the entire English blog archive. Select the evidence and decision content needed by the local buyer. Translate a prior article only when its product, claim, market and search job are still valid. Otherwise write the local page from the approved evidence source.

Days 36–60: technical launch and priority market pages

Release the three locale cores behind full technical checks. Launch the Germany, Austria, Korea and Spain country journeys. Add the highest-priority lighter pages that pass their gates: typically en-US, Netherlands and one of Japan, France or the UK based on actual company readiness.

The reason not to launch all 12 market pages in the same sprint is operational learning. The team needs to see whether forms route correctly, reviewers can keep pace, hreflang clusters reflect real equivalents and the country fields are sufficient. Fix the system before multiplying it.

The release checklist should produce evidence, not only green checkmarks:

• crawl export of canonical/indexable URLs;
• hreflang equivalence test with reciprocal pairs;
• screenshots and human review at target breakpoints;
• successful test contacts reaching the named owner;
• page-to-claim-source mapping;
• product availability confirmation dated at release;
• analytics test event with language and market dimensions;
• redirect/rollback record.

Days 61–90: native evidence, distribution and measurement

Use local sales, service and distributor questions to create the first native content—not translated corporate news. Good candidates include product selection criteria, clinical workflow, compatibility, installation, training, service, warranty, procurement documents and evidence interpretation. Every page should have a market job and a cited source.

Distribute the useful pages through the channels the local commercial owner actually operates. A distributor enablement email, local LinkedIn post, trade- association reference or properly reviewed announcement can create the first qualified visits. Distribution does not substitute for the owned evidence; it helps the right audience encounter it.

Review weekly leading indicators and monthly decision indicators:

Stop, maintain and expand decisions on day 90

Set numeric thresholds from the company's own baseline and sales economics, not universal percentages invented in this report.

• Expand when the locale shows repeat relevant discovery or qualified use, the commercial owner closes the loop, service performs and claims stay within SLA. Add the next product/application cluster or promote the strongest market page toward a fuller locale.
• Maintain when demand evidence is early but the page answers a necessary buyer/support job at acceptable upkeep. Keep the bounded scope and collect another decision window.
• Narrow when traffic is broad but contacts are unqualified, distributor use is absent or the page job is unclear. Rewrite around the actual buyer question before creating more pages.
• Stop or defer when access changes, the product is unavailable, service is unsupported, no owner responds, claims cannot be maintained or the market produces no decision-grade evidence relative to its cost. Redirect retired pages intentionally and preserve required product information.

This is the discipline that makes localization reversible. A giant translated site creates sunk-cost pressure. A governed core plus staged market pages gives management permission to stop weak paths and deepen strong ones.

9. How to rerun the method for another medical device

Takeaway: Keep the decision architecture; replace the demand cohort and company gates. Never reuse the ultrasound rank as a universal medtech answer.

Step 1: define one product cohort

Specify the product family, intended use, buyer and relevant classification. Choose a demand measure that actually moves with that product: trade flows, procedures, tenders, installed base, test volume or another defensible lane. Record coverage, unit, time period and exclusions.

If one HS code contains too many unrelated products, narrow or triangulate it. If the product is locally manufactured and rarely crosses borders, imports may be a poor demand proxy. If no independent demand lane exists, do not hide the gap with population and GDP. Narrow the claim.

Step 2: freeze the screen and weights before looking at winners

Define the candidate universe, common observation year, missing policy, transforms, caps and weights. Keep demand the majority unless the decision has a documented reason to prioritize something else. Preserve the raw values beside the score.

Step 3: run plausible counterfactuals

Create at least demand-heavy, digital-first, service/operations-heavy and equal- weight alternatives. Examine rank range and top-ten/top-15 membership. Do not argue over two decimals.

Step 4: apply company-specific gates

For the top 15, record product access, commercial owner, service, evidence/claims and language operations. A company already selling through a mature Brazilian partner may rationally promote Brazil above a model Tier B market. That is a better decision because the override is explicit and evidenced.

Step 5: select the language portfolio

Convert markets into country journeys, then identify reusable language cores. Score asset reuse only after preserving market-specific product, contact and claims fields. Select three full locales, a bounded page queue and revisit triggers.

Step 6: measure and update

Rerun the quantitative panel when a new complete demand year arrives, when the product cohort changes or when a major commercial fact changes. Do not rerank weekly from noisy partial data. Update operating gates whenever approval, distribution, service or claims status changes.

10. Frequently asked questions

Which languages should a medical device company translate first?

There is no universal list. In this diagnostic-ultrasound worked example, the first three full working locales are German, Korean and Spanish for Spain. The choice follows product-specific demand, sensitivity and operating gates—not the largest populations. A different device or existing distributor network can produce a different result.

Should we translate the whole medical device website at once?

Usually no. Launch the complete buyer decision path for the selected market: product/category, applications, evidence, quality/regulatory routing, service, contact and FAQs. A smaller maintained locale is more useful than a large stale translation. Translate additional articles only when they have a current local job.

Is a country page enough for international SEO?

A country page can be enough to validate one market question, but technical implementation alone is not a demand strategy. It needs a unique, truthful market purpose; local product and support facts; discoverable terminology; internal links; correct canonical/indexing; and measurement. hreflang helps search systems understand genuine alternatives; it does not create relevance or authority [19][20].

Should a medtech company use ccTLDs or subdirectories?

For a limited team, one .com with language subdirectories is usually the lower-maintenance default. Register important ccTLDs defensively after checking eligibility, trademark, cost and security, then redirect them to real country journeys. Use separate ccTLD sites only when the market's legal or operating model justifies separate infrastructure [19][22].

Does translating the website satisfy medical-device language requirements?

No. Website marketing, labels, IFUs/e-labels, safety notices and declarations can have different legal requirements, review owners and update duties. Connect the website to current controlled product information, but do not treat a translated web page as regulatory clearance [8].

How do we choose between a full locale and one market page?

Use a full locale when the market is a stable priority and the company can maintain a complete local buyer journey. Use a market page when demand is material but ranking, channel, access, service or language operations still need validation. A hard access or service failure means defer, not “publish and see.”

How many markets should we launch in 90 days?

This plan launches three language cores and four first-wave country journeys: Germany, Austria, Korea and Spain. It then adds a small number of page tests, typically US, Netherlands and one readiness-led Tier B market. The point is to learn and correct the operating system before multiplying pages.

How should we measure localization ROI?

Start with the pre-launch baseline. Track local non-branded query impressions, engaged use of product/evidence/service pages, qualified contacts and their disposition, distributor use, response time and claim-update performance. Compare the value of qualified outcomes and channel enablement with production and maintenance cost. Traffic alone is not ROI.

11. Conclusion: localization depth should follow the commercial decision

The headline rank is not the answer. The worked example puts the United States, Netherlands and Germany at the top, yet the first-wave language decision is German, Korean and Spanish. That difference is the value of the method.

Germany combines stable product flow and operating context with an Austrian reuse opportunity. Korea combines a stable top-ten case, positive recent direction and a real Korean-language operating need. Spain combines stability, positive product-flow direction and a reusable Spanish content core. Japan and China are important, but their sensitivity and recent direction argue for controlled validation rather than automatic full-site investment.

The system behind those choices matters more than the translation vendor. One team must maintain the site architecture, language cores, country-specific claims, evidence, domains, ongoing content, distribution and measurement. VayoMed's current Done-for-You Global Growth Engine packages the global website, operations and maintenance, LinkedIn, domain portfolio, source-grounded content/GEO and monthly PR distribution at $24,000 per year [23]. Its published content scope is 110–180 source-grounded articles per year [24].

That service can operate the public-evidence and growth layer. It does not grant market access, replace regulatory/medical review or guarantee rankings, traffic, AI mentions, distributors, leads or revenue. The client still owns the product, approval, claims and commercial decisions.

The Monday-morning action is concrete: replace HS 901812 with the company's product-demand cohort; mark the top 15 pass/fail on access, owner, service, evidence and language operations; approve three full locales; and assign every other market to page, English-only or defer. Then build only what the company can keep true.

Methodology and limitations

Analytical lineage

The market screen uses VayoMed Research's 29 August 2026 R2 snapshot of a World Bank annual indicator panel. R2 was inspected before local data. Of 217 entities with a 2022 row, 132 had every required macro input; the 40 largest computed current-health-expenditure totals formed the candidate set. No macro value was imputed.

The product cohort uses CEPII BACI HS17 V202601, released 22 January 2026 and covering 2017–2024. We scanned the 2022, 2023 and 2024 bilateral files, selected HS 901812, summed value by importer and converted the source's thousand-dollar unit to current US dollars. Modern Germany code 276 and Belgium code 56 were selected explicitly because the BACI country file also retains historical duplicates. The script, model specification, 40-country outputs and chart generator are preserved with this report.

The R2 HTTP Archive and IANA snapshots were used only for their respective implementation and domain-status questions. They were not treated as demand. The R2 ultrasound/Comtrade candidate was rejected because its 136,421-row 2024 file had no usable reporter or partner country fields.

What the model cannot establish

• HS 901812 trade is not manufacturer sales, profit, installed base, procedures, tenders, final domestic consumption or buyer intent.
• BACI is a reconciled trade dataset and may differ from raw customs declarations. Re-export hubs can overstate domestic opportunity.
• The World Bank inputs are structural context and mostly 2022 for aligned comparison. LPI is perception-based.
• The composite weights express one transparent decision policy. Five scenarios reduce but do not eliminate judgment.
• Official language sources support bounded regulatory statements. They do not constitute legal advice for a particular product, audience or transaction.
• Local query checks were conducted on 29 August 2026 and record page types observed for exact queries. They have no search-volume denominator and do not measure AI visibility.
• The publishing-depth matrix assumes an English source site and no undisclosed company-specific approval, channel or service advantage. Actual gates override it.
• The model is a diagnostic-ultrasound worked example. Reusing its country order for another device without replacing the demand lane is misuse.

Sources

1. CEPII, BACI: International Trade Database at the Product-Level, version 202601, released January 22, 2026. VayoMed Research calculations for HS 901812, 2022–2024; accessed August 29, 2026.

1. World Bank, Current health expenditure (% of GDP), metadata, accessed August 29, 2026.

1. World Bank, Logistics performance index: Overall, metadata, accessed August 29, 2026.

1. Federal Ministry of Justice and Federal Office of Justice, Germany, Medical Devices Implementation Act (MPDG), §8, current text accessed August 29, 2026.

1. Republic of Korea, National Law Information Center, Medical Devices Act, Article 23, accessed August 29, 2026.

1. Spanish Agency of Medicines and Medical Devices (AEMPS), Requirements for medical devices marketed in Spain, accessed August 29, 2026.

1. State Administration for Market Regulation, China, Regulations on the Supervision and Administration of Medical Devices, accessed August 29, 2026.

1. European Parliament and Council, Regulation (EU) 2017/745 on medical devices, consolidated text accessed August 29, 2026.

1. French Republic, Légifrance, Code de la santé publique, Article R5211-3, version in force from April 22, 2026; accessed August 29, 2026.

1. Pharmaceuticals and Medical Devices Agency (PMDA), Japan, Electronic package inserts, accessed August 29, 2026.

1. US Electronic Code of Federal Regulations, 21 CFR §801.15—Prominence of required label statements, accessed August 29, 2026.

1. Justice Laws Website, Canada, Medical Devices Regulations, SOR/98-282, §23, accessed August 29, 2026.

1. UK Medicines and Healthcare products Regulatory Agency, Medical devices: how to comply with the legal requirements in Great Britain, accessed August 29, 2026.

1. Australian Therapeutic Goods Administration, Medical devices: labelling and information, accessed August 29, 2026.

1. AMT Abken Medizintechnik, German medical-ultrasound commercial site, observed for the exact bounded German query on August 29, 2026.

1. Health Insurance Review & Assessment Service, Republic of Korea, Korean health-information result, observed for the exact bounded Korean query on August 29, 2026.

1. Saitama Prefectural Hospitals, Japan, Public procurement notice (PDF), observed for the exact bounded Japanese query on August 29, 2026.

1. Esaote France, Échographes product catalogue, observed for the exact bounded French query on August 29, 2026.

1. Google Search Central, Managing multi-regional and multilingual sites, accessed August 29, 2026.

1. Google Search Central, Tell Google about localized versions of your page, accessed August 29, 2026.

1. HTTP Archive, Web Almanac 2025, SEO, accessed August 29, 2026.

1. Internet Assigned Numbers Authority, Root Zone Database, accessed August 29, 2026.

1. VayoMed, Done-for-You Global Growth Engine, current offer and pricing accessed August 29, 2026.

1. VayoMed, AI Content Engine, current scope accessed August 29, 2026.